Corindus Vascular Robotics (NYSEAMERICAN:CVRS) released its quarterly earnings results on Tuesday, August 7th. The medical equipment provider reported ($0.06) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.01), Bloomberg Earnings reports. The firm had revenue of $1.67 million for the quarter, compared to analysts’ expectations of $3.00 million. Corindus Vascular Robotics had a negative net margin of 323.84% and a negative return on equity of 110.93%.
CVRS traded up $0.01 during trading on Friday, hitting $1.09. The company’s stock had a trading volume of 304,800 shares, compared to its average volume of 1,029,320. Corindus Vascular Robotics has a one year low of $0.66 and a one year high of $1.97.
Several equities analysts have recently commented on the stock. Zacks Investment Research downgraded shares of Corindus Vascular Robotics from a “buy” rating to a “hold” rating in a research note on Tuesday, August 14th. Stifel Nicolaus downgraded shares of Corindus Vascular Robotics from a “buy” rating to a “hold” rating and lowered their price objective for the company from $3.00 to $1.00 in a research note on Wednesday, August 8th. Finally, LADENBURG THALM/SH SH initiated coverage on shares of Corindus Vascular Robotics in a research note on Monday, May 21st. They set a “buy” rating and a $2.00 price objective for the company. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the company. The company presently has an average rating of “Hold” and a consensus price target of $1.50.
Corindus Vascular Robotics Company Profile
Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted precision vascular systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures.
Recommended Story: Book Value Per Share – BVPS
Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.